• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

2 Mooning Stocks with Promising Prospects and 1 to Approach with Caution

By: StockStory
June 26, 2025 at 00:31 AM EDT

NVDA Cover Image

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

But not every company with momentum is a long-term winner, and plenty of investors have lost money betting on short-term fads. Keeping that in mind, here are two stocks we think live up to the hype and one that may correct.

One Stock to Sell:

CVS Health (CVS)

One-Month Return: +8.1%

With over 9,000 retail pharmacy locations serving as neighborhood health destinations across America, CVS Health (NYSE: CVS) operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance through its Aetna subsidiary.

Why Does CVS Give Us Pause?

  1. Sizable revenue base leads to growth challenges as its 7% annual revenue increases over the last two years fell short of other healthcare companies
  2. Estimated sales growth of 2.5% for the next 12 months implies demand will slow from its two-year trend
  3. Earnings per share fell by 2.9% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable

CVS Health’s stock price of $66.33 implies a valuation ratio of 10.8x forward P/E. Check out our free in-depth research report to learn more about why CVS doesn’t pass our bar.

Two Stocks to Watch:

Nvidia (NVDA)

One-Month Return: +14.1%

Founded in 1993 by Jensen Huang and two former Sun Microsystems engineers, Nvidia (NASDAQ: NVDA) is a leading fabless designer of chips used in gaming, PCs, data centers, automotive, and a variety of end markets.

Why Will NVDA Outperform?

  1. Market share has increased this cycle as its 140% annual revenue growth over the last two years was exceptional
  2. Share repurchases have amplified shareholder returns as its annual earnings per share growth of 80.2% exceeded its revenue gains over the last five years
  3. Robust free cash flow margin of 48.8% gives it many options for capital deployment, and its growing cash flow gives it even more resources to deploy

At $154.60 per share, Nvidia trades at 32.7x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

ESCO (ESE)

One-Month Return: +4.2%

A developer of the communication systems used in the Batmobile of “The Dark Knight,” ESCO (NYSE: ESE) is a provider of engineered components for the aerospace, defense, and utility sectors.

Why Does ESE Catch Our Eye?

  1. Demand for the next 12 months is expected to accelerate above its two-year trend as Wall Street forecasts robust revenue growth of 18.2%
  2. Offerings are difficult to replicate at scale and result in a stellar gross margin of 38.9%
  3. Earnings per share grew by 20.7% annually over the last two years and trumped its peers

ESCO is trading at $190.33 per share, or 30.7x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.

Stocks We Like Even More

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as ServiceNow (+178% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

More News

View More
Falling Fast, Rising Soon? 3 Stocks With Upside Ahead
Today 16:22 EDT
Via MarketBeat
Topics Earnings
Tickers ALLT ARDT GPI
The Top 120 Lesser-Known Affordable Luxury Vacation Spots in the U.S.
Today 16:15 EDT
Via MarketBeat
Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound
Today 16:13 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers LLY PFE UNH
Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings?
Today 13:41 EDT
Via MarketBeat
Topics Earnings
Tickers T TMUS VZ
AST SpaceMobile: A New Asset Class Held Down by Outdated Models
Today 13:31 EDT
Via MarketBeat
Tickers ASTS KTOS T VOD
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap